Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3
- PMID: 24858423
- DOI: 10.1016/j.jacc.2014.05.012
Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3
Abstract
Background: Prior studies of catheter-based renal artery denervation have not systematically performed ambulatory blood pressure monitoring (ABPM) to assess the efficacy of the procedure.
Objectives: SYMPLICITY HTN-3 (Renal Denervation in Patients With Uncontrolled Hypertension) was a prospective, blinded, randomized, sham-controlled trial. The current analysis details the effect of renal denervation or a sham procedure on ABPM measurements 6 months post-randomization.
Methods: Patients with resistant hypertension were randomized 2:1 to renal denervation or sham control. Patients were on a stable antihypertensive regimen including maximally tolerated doses of at least 3 drugs including a diuretic before randomization. The powered secondary efficacy endpoint was a change in mean 24-h ambulatory systolic blood pressure (SBP). Nondipper to dipper (nighttime blood pressure [BP] 10% to 20% lower than daytime BP) conversion was calculated at 6 months.
Results: The 24-h ambulatory SBP changed -6.8 ± 15.1 mm Hg in the denervation group and -4.8 ± 17.3 mm Hg in the sham group: difference of -2.0 mm Hg (95% confidence interval [CI]: -5.0 to 1.1; p = 0.98 with a 2 mm Hg superiority margin). The daytime ambulatory SBP change difference between groups was -1.1 (95% CI: -4.3 to 2.2; p = 0.52). The nocturnal ambulatory SBP change difference between groups was -3.3 (95 CI: -6.7 to 0.1; p = 0.06). The percent of nondippers converted to dippers was 21.2% in the denervation group and 15.0% in the sham group (95% CI: -3.8% to 16.2%; p = 0.30). Change in 24-h heart rate was -1.4 ± 7.4 in the denervation group and -1.3 ± 7.3 in the sham group; (95% CI: -1.5 to 1.4; p = 0.94).
Conclusions: This trial did not demonstrate a benefit of renal artery denervation on reduction in ambulatory BP in either the 24-h or day and night periods compared with sham (Renal Denervation in Patients With Uncontrolled Hypertension [SYMPLICITY HTN-3]; NCT01418261).
Keywords: ambulatory blood pressure monitoring; renal denervation; resistant hypertension.
Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Comment in
-
Renal denervation for resistant hypertension: not dead yet.J Am Coll Cardiol. 2014 Sep 16;64(11):1088-91. doi: 10.1016/j.jacc.2014.07.947. J Am Coll Cardiol. 2014. PMID: 25212641 No abstract available.
-
A mechanistic explanation for the minimal impact of renal denervation on 24-h ambulatory blood pressure in SIMPLICITY HTN-3.J Am Coll Cardiol. 2015 Mar 10;65(9):959. doi: 10.1016/j.jacc.2014.10.076. J Am Coll Cardiol. 2015. PMID: 25744017 No abstract available.
-
Reply: A mechanistic explanation for the minimal impact of renal denervation on 24-h ambulatory blood pressure in SIMPLICITY HTN-3.J Am Coll Cardiol. 2015 Mar 10;65(9):959-60. doi: 10.1016/j.jacc.2014.11.058. J Am Coll Cardiol. 2015. PMID: 25744018 No abstract available.
Similar articles
-
12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial.J Am Coll Cardiol. 2015 Apr 7;65(13):1314-1321. doi: 10.1016/j.jacc.2015.01.037. J Am Coll Cardiol. 2015. PMID: 25835443 Clinical Trial.
-
Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial.Lancet. 2022 Oct 22;400(10361):1405-1416. doi: 10.1016/S0140-6736(22)01787-1. Epub 2022 Sep 18. Lancet. 2022. PMID: 36130612 Clinical Trial.
-
Renal denervation in moderate treatment-resistant hypertension.J Am Coll Cardiol. 2013 Nov 12;62(20):1880-6. doi: 10.1016/j.jacc.2013.06.023. Epub 2013 Jul 10. J Am Coll Cardiol. 2013. PMID: 23850901 Clinical Trial.
-
Renal denervation therapy for the treatment of resistant hypertension: a position statement by the Canadian Hypertension Education Program.Can J Cardiol. 2014 Jan;30(1):16-21. doi: 10.1016/j.cjca.2013.07.008. Epub 2013 Oct 23. Can J Cardiol. 2014. PMID: 24269056 Review.
-
Percutaneous renal sympathetic denervation: 2013 and beyond.Can J Cardiol. 2014 Jan;30(1):64-74. doi: 10.1016/j.cjca.2013.11.003. Epub 2013 Nov 7. Can J Cardiol. 2014. PMID: 24365191 Review.
Cited by
-
Effect of renal denervation on long-term outcomes in patients with resistant hypertension.Cardiovasc Diabetol. 2021 Jun 5;20(1):117. doi: 10.1186/s12933-021-01309-3. Cardiovasc Diabetol. 2021. PMID: 34090434 Free PMC article. Review.
-
The cholinergic anti-inflammatory pathway in resistant hypertension treated with renal denervation.Mol Med. 2019 Aug 15;25(1):39. doi: 10.1186/s10020-019-0097-y. Mol Med. 2019. PMID: 31416428 Free PMC article.
-
Autonomic nerves and circadian control of renal function.Auton Neurosci. 2019 Mar;217:58-65. doi: 10.1016/j.autneu.2019.01.003. Epub 2019 Jan 10. Auton Neurosci. 2019. PMID: 30704976 Free PMC article. Review.
-
Non-contrast-enhanced MRA of renal artery stenosis: validation against DSA in a porcine model.Eur Radiol. 2016 Feb;26(2):547-55. doi: 10.1007/s00330-015-3833-x. Epub 2015 May 28. Eur Radiol. 2016. PMID: 26017736
-
Neuraxial modulation for treatment of VT storm.J Biomed Res. 2015 Jan;29(1):56-60. doi: 10.7555/JBR.29.20140161. Epub 2014 Dec 28. J Biomed Res. 2015. PMID: 25745476 Free PMC article. Review.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical